The ratio of FoxA1 to FoxA2 in lung adenocarcinoma is regulated by LncRNA HOTAIR and chromatin remodeling factor LSH

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Wang, Ranran ^a   Shi, Ying ^b,c,d   Chen, Ling ^b,c,d   Jiang, Yiqun ^b,c,d   Mao, Chao ^b,c,d   Yan, Bin ^b,c,d   Liu, Shuang ^e   Shan, Bin ^f   Tao, Yongguang ^b,c,d   Wang, Xiang ^a,b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^d BEIJING HOSPITAL   (China)

^e CENTRAL SOUTH UNIVERSITY   (China)

^f WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA HELICASE; FOXA1 PROTEIN, HUMAN; FOXA2 PROTEIN, HUMAN; HELLS PROTEIN, HUMAN; HEPATOCYTE NUCLEAR FACTOR 3ALPHA; HEPATOCYTE NUCLEAR FACTOR 3BETA; HOTAIR LONG UNTRANSLATED RNA, HUMAN; LONG UNTRANSLATED RNA; PROTEIN BINDING; TUMOR MARKER;

ADENOCARCINOMA; CANCER GRADING; CANCER STAGING; CELL MOTION; CHROMATIN ASSEMBLY AND DISASSEMBLY; FEMALE; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; HUMAN; LUNG TUMOR; MALE; METABOLISM; METASTASIS; PATHOLOGY; TUMOR CELL LINE;

ADENOCARCINOMA; BIOMARKERS, TUMOR; CELL LINE, TUMOR; CELL MOVEMENT; CHROMATIN ASSEMBLY AND DISASSEMBLY; DNA HELICASES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HEPATOCYTE NUCLEAR FACTOR 3-ALPHA; HEPATOCYTE NUCLEAR FACTOR 3-BETA; HUMANS; LUNG NEOPLASMS; MALE; NEOPLASM GRADING; NEOPLASM METASTASIS; NEOPLASM STAGING; PROTEIN BINDING; RNA, LONG NONCODING;

EID: 84949660073     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep17826     Document Type: Article

References (46)

1. Siegel, R., Naishadham, D. & Jemal, A. Cancer statistics, 2012. CA: a cancer journal for clinicians 62, 10-29 (2012).
2. Reck, M., Heigener, D. F., Mok, T., Soria, J. C. & Rabe, K. F. Management of non-small-cell lung cancer: recent developments. Lancet 382, 709-719 (2013).
3. Rinn, J. L. & Chang, H. Y. Genome regulation by long noncoding RNAs. Annual review of biochemistry 81, 145-166 (2012).
4. Chu, C., Qu, K., Zhong, F. L., Artandi, S. E. & Chang, H. Y. Genomic maps of long noncoding RNA occupancy reveal principles of RNA-chromatin interactions. Mol Cell 44, 667-678 (2011).
5. Gupta, R. A. et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 464, 1071-1076 (2010).
6. Rinn, J. L. et al. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell 129, 1311-1323 (2007).
7. Kim, K. et al. HOTAIR is a negative prognostic factor and exhibits pro-oncogenic activity in pancreatic cancer. Oncogene 32, 1616-1625 (2013).
8. Kogo, R. et al. Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers. Cancer Res 71, 6320-6326 (2011).
9. Padua Alves, C. et al. Brief report: The lincRNA Hotair is required for epithelial-to-mesenchymal transition and stemness maintenance of cancer cell lines. Stem Cells 31, 2827-2832 (2013).
10. Khalil, A. M. et al. Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc Natl Acad Sci USA 106, 11667-11672 (2009).
11. Li, L. et al. Targeted disruption of Hotair leads to homeotic transformation and gene derepression. Cell Rep 5, 3-12 (2013).
12. Zemach, A. et al. The Arabidopsis nucleosome remodeler DDM1 allows DNA methyltransferases to access H1-containing heterochromatin. Cell 153, 193-205 (2013).
13. Yu, W. et al. Genome-wide DNA methylation patterns in LSH mutant reveals de-repression of repeat elements and redundant epigenetic silencing pathways. Genome research 24, 1613-1623 (2014).
14. Tao, Y. et al. Lsh, chromatin remodeling family member, modulates genome-wide cytosine methylation patterns at nonrepeat sequences. Proceedings of the National Academy of Sciences of the United States of America 108, 5626-5631 (2011).
15. Myant, K. et al. LSH and G9a/GLP complex are required for developmentally programmed DNA methylation. Genome research 21, 83-94 (2011).
16. Keyes, W. M. et al. DeltaNp63alpha is an oncogene that targets chromatin remodeler Lsh to drive skin stem cell proliferation and tumorigenesis. Cell stem cell 8, 164-176 (2011).
17. von Eyss, B. et al. The SNF2-like helicase HELLS mediates E2F3-dependent transcription and cellular transformation. EMBO J 31, 972-985 (2012).
18. Mozzetta, C. et al. The histone H3 lysine 9 methyltransferases G9a and GLP regulate polycomb repressive complex 2-mediated gene silencing. Mol Cell 53, 277-289 (2014).
19. Kaestner, K. H. The FoxA factors in organogenesis and differentiation. Curr Opin Genet Dev 20, 527-532 (2010).
20. Friedman, J. R. & Kaestner, K. H. The Foxa family of transcription factors in development and metabolism. Cellular and molecular life sciences : CMLS 63, 2317-2328 (2006).
21. Lee, C. S., Friedman, J. R., Fulmer, J. T. & Kaestner, K. H. The initiation of liver development is dependent on Foxa transcription factors. Nature 435, 944-947 (2005).
22. Wan, H. et al. Compensatory roles of Foxa1 and Foxa2 during lung morphogenesis. The Journal of biological chemistry 280, 13809-13816 (2005).
23. Li, Z., Tuteja, G., Schug, J. & Kaestner, K. H. Foxa1 and Foxa2 are essential for sexual dimorphism in liver cancer. Cell 148, 72-83 (2012).
24. Bochkis, I. M. et al. Genome-wide location analysis reveals distinct transcriptional circuitry by paralogous regulators Foxa1 and Foxa2. PLoS Genet 8, e1002770 (2012).
25. Xi, S. et al. Lsh controls Hox gene silencing during development. Proc Natl Acad Sci USA 104, 14366-14371 (2007).
26. Heubach, J. et al. The long noncoding RNA HOTAIR has tissue and cell type-dependent effects on HOX gene expression and phenotype of urothelial cancer cells. Mol Cancer 14, 108 (2015).
27. Li, L. et al. Infiltrating mast cells enhance prostate cancer invasion via altering LncRNA-HOTAIR/PRC2-androgen receptor (AR)-MMP9 signals and increased stem/progenitor cell population. Oncotarget 6, 14179-14190 (2015).
28. Loewen, G., Jayawickramarajah, J., Zhuo, Y. & Shan, B. Functions of lncRNA HOTAIR in lung cancer. Journal of hematology & oncology 7, 90 (2014).
29. Svoboda, M. et al. HOTAIR long non-coding RNA is a negative prognostic factor not only in primary tumors, but also in the blood of colorectal cancer patients. Carcinogenesis 35, 1510-1515 (2014).
30. Wang, Y. L. et al. Combined inhibition of EGFR and c-ABL suppresses the growth of triple-negative breast cancer growth through inhibition of HOTAIR. Oncotarget 6, 11150-11161 (2015).
31. Yang, G. et al. Osteopontin enhances the expression of HOTAIR in cancer cells via IRF1. Biochim Biophys Acta 1839, 837-848 (2014).
32. Zhuang, Y. et al. Induction of long intergenic non-coding RNA HOTAIR in lung cancer cells by type I collagen. Journal of hematology & oncology 6, 35 (2013).
33. Tsai, M. C. et al. Long Noncoding RNA as Modular Scaffold of Histone Modification Complexes. Science 329, 689-693 (2010).
34. Kirmizis, A. et al. Silencing of human polycomb target genes is associated with methylation of histone H3 Lys 27. Genes Dev 18, 1592-1605 (2004).
35. Shi, Y. et al. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell 119, 941-953 (2004).
36. Fan, T. et al. Lsh-deficient murine embryonal fibroblasts show reduced proliferation with signs of abnormal mitosis. Cancer Res 63, 4677-4683 (2003).
37. Burrage, J. et al. The SNF2 family ATPase LSH promotes phosphorylation of H2AX and efficient repair of DNA double-strand breaks in mammalian cells. Journal of cell science 125, 5524-5534 (2012).
38. Waseem, A., Ali, M., Odell, E. W., Fortune, F. & Teh, M. T. Downstream targets of FOXM1: CEP55 and HELLS are cancer progression markers of head and neck squamous cell carcinoma. Oral oncology 46, 536-542 (2010).
39. Ryu, B., Kim, D. S., Deluca, A. M. & Alani, R. M. Comprehensive expression profiling of tumor cell lines identifies molecular signatures of melanoma progression. PLoS One 2, e594 (2007).
40. Yano, M. et al. Tumor-specific exon creation of the HELLS/SMARCA6 gene in non-small cell lung cancer. Int J Cancer 112, 8-13 (2004).
41. Song, Y., Washington, M. K. & Crawford, H. C. Loss of FOXA1/2 is essential for the epithelial-to-mesenchymal transition in pancreatic cancer. Cancer Res 70, 2115-2125 (2010).
42. Wang, H. et al. A systematic approach identifies FOXA1 as a key factor in the loss of epithelial traits during the epithelial-tomesenchymal transition in lung cancer. BMC genomics 14, 680 (2013).
43. Zhang, Z. et al. FOXA2 attenuates the epithelial to mesenchymal transition by regulating the transcription of E-cadherin and ZEB2 in human breast cancer. Cancer letters 361, 240-250 (2015).
44. Tang, Y., Shu, G., Yuan, X., Jing, N. & Song, J. FOXA2 functions as a suppressor of tumor metastasis by inhibition of epithelialto-mesenchymal transition in human lung cancers. Cell research 21, 316-326 (2011).
45. Jiang, Y. et al. Repression of Hox genes by LMP1 in nasopharyngeal carcinoma and modulation of glycolytic pathway genes by HoxC8. Oncogene. doi: 10.1038/onc.2015.53 (2015).
46. Shi, Y. et al. Nuclear epidermal growth factor receptor interacts with transcriptional intermediary factor 2 to activate cyclin D1 gene expression triggered by the oncoprotein latent membrane protein 1. Carcinogenesis 33, 1468-1478 (2012).